Former Emisphere investors sue following sale to Novo Nordisk

The USD 1.8bn price does not reflect the value of Emisphere, according to former Emisphere shareholders, who have sued MHR Fund Management.
Photo: Novo Nordisk / PR
Photo: Novo Nordisk / PR
BY MAIKEN REIMER RØNNEBERG, TRANSLATED BY NIELSINE NIELSEN

Last year, Novo Nordisk bought US company Emisphere Technologies for USD 1.8bn. Former investors in Emisphere are now suing the company's largest shareholder, MHR Fund Management, according to Fierce Pharma.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading